SCHEMBL19212237

SCHEMBL19212237

O=C(O)N1CCN(c2c(F)cc(Br)c(F)c2F)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
KDM4E B2RXH2 7/20 0.38
HPGD P15428 3/20 0.36
LMNA P02545 2/20 0.36
ALOX15 P16050 2/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
ALOX12 P18054 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
POLB P06746 2/20 0.36
PKM P14618 1/20 0.36
ALDH1A1 P00352 7/20 0.35
HTT P42858 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19212451 0.79 GPR119 (0.47) SMN1; SMN2HPGDLMNAALOX15USP2
SCHEMBL29707311 0.79 GPR119 (0.47) SMN1; SMN2HPGDLMNAALOX15USP2
SCHEMBL17422311 0.77 KDM4E (0.37) SMN1; SMN2MEN1KMT2AKDM4EHPGD
SCHEMBL19212177 0.77 KDM4E (0.41) SMN1; SMN2MEN1KMT2AKDM4EHPGD
SCHEMBL19212179 0.76 ALDH1A1 (0.43) SMN1; SMN2MEN1KMT2AKDM4EHPGD
SCHEMBL11352178 0.76 BTK (0.38) SMN1; SMN2MEN1KMT2AKDM4EHPGD
SCHEMBL28866522 0.74 KDM4E (0.33) SMN1; SMN2MEN1KMT2AKDM4EHPGD
SCHEMBL29173633 0.73 CA12 (0.47) SMN1; SMN2MEN1KMT2AKDM4EHPGD
SCHEMBL17422299 0.73 ALDH1A1 (0.44) SMN1; SMN2MEN1KMT2AKDM4ELMNA
SCHEMBL28094905 0.72 LMNA (0.43) SMN1; SMN2KDM4ELMNAALOX15USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414252-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2018-12-19 EP disclosed
WO-2017139778-A1 THIENOPYRIDINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2017-08-17 WO disclosed